BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients ...
Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...
Predictions for identifying 1-year seizure recurrence performed significantly better in electroencephalography (EEG) without interictal epileptiform discharges. An automated processing algorithm ...
Researchers have developed a new AI-powered algorithm to help understand how different cells organize themselves into particular tissues and communicate with one another. Researchers from Children's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results